Citadel Advisors’s iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN SGG Stock Holding History

Citadel Advisors’s Portfolio SGG Stock Details SGG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-500	Closed	-$38.3K	–	15819
2023 Q1	$38.3K	Sell	500 -1,400	-74%	-$94.7K	﹤0.01%	12474
2022 Q4	$120K	Buy	+1,900	New	+$115K	﹤0.01%	10954
2019 Q1	–	Sell	-12,700	Closed	-$527K	–	10443
2018 Q4	$527K	Buy	12,700 +6,300	+98%	+$279K	﹤0.01%	6317
2018 Q3	$245K	Sell	6,400 -5,100	-44%	-$202K	﹤0.01%	7909
2018 Q2	$514K	Buy	+11,500	New	+$515K	﹤0.01%	6324

Citadel Advisors's SGG Position: Q4 2021 in Review

Citadel Advisors sold out of iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN (SGG) in Q4 2021, closing a stake of 4,161 shares — an estimated $253K sold.

Citadel Advisors first reported a position in SGG in Q3 2018 and held it in 7 quarters. The position peaked at $286K in Q3 2018. 11 funds tracked by Wall St. Rank hold SGG as of Q4 2021.

Citadel Advisors reported no remaining iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN position as of Q4 2021 after selling out during the quarter.
Citadel Advisors sold 4,161 iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN shares in Q4 2021, an estimated $253K.
Citadel Advisors first reported a position in iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN in Q3 2018 and held it in 7 quarters.
Citadel Advisors's iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN position peaked at $286K in Q3 2018.
11 funds tracked by Wall St. Rank held iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN as of Q4 2021.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.